blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0530311

EP0530311 - THE USE OF PHENYLPROPANOLAMINE AS A MUCUS SECRETAGOGUE IN THE UPPER AIRWAYS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  01.11.1996
Database last updated on 05.10.2024
Most recent event   Tooltip01.11.1996Application deemed to be withdrawnpublished on 18.12.1996 [1996/51]
Applicant(s)For all designated states
Norwich-Eaton Pharmaceuticals, Inc.
17 Eaton Avenue
Norwich, New York 13815 / US
[1993/10]
Inventor(s)01 / PHIPPS, Roger, John
36 Chenango Avenue
Sherburne, NY 13460 / US
[1993/10]
Representative(s)Brooks, Maxim Courtney
Procter & Gamble Technical Centres Limited
Whitley Road
Longbenton
Newcastle-upon-Tyne
NE12 9TS / GB
[N/P]
Former [1993/10]Brooks, Maxim Courtney
Procter & Gamble Limited Whitley Road Longbenton
Newcastle-upon-Tyne NE12 9TS / GB
Application number, filing date91911164.117.05.1991
[1993/10]
WO1991US03453
Priority number, dateUS1990052621821.05.1990         Original published format: US 526218
[1993/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9117746
Date:28.11.1991
Language:EN
[1991/27]
Type: A1 Application with search report 
No.:EP0530311
Date:10.03.1993
Language:EN
The application published by WIPO in one of the EPO official languages on 28.11.1991 takes the place of the publication of the European patent application.
[1993/10]
Search report(s)International search report - published on:EP28.11.1991
ClassificationIPC:A61K31/135
[1993/10]
CPC:
A61K31/621 (EP); A61K31/135 (EP); A61K31/165 (EP);
A61K31/19 (EP); A61K31/195 (EP); A61K31/42 (EP);
A61K31/43 (EP); A61K31/44 (EP); A61K31/445 (EP);
A61K31/485 (EP); A61K31/495 (EP); A61K31/505 (EP);
A61K31/54 (EP); A61K31/60 (EP); A61P11/10 (EP) (-)
C-Set:
A61K31/135, A61K2300/00 (EP);
A61K31/135, A61K31/055, A61K31/045, A61K31/09 (EP);
A61K31/165, A61K2300/00 (EP);
A61K31/195, A61K2300/00 (EP);
A61K31/19, A61K2300/00 (EP);
A61K31/42, A61K2300/00 (EP);
A61K31/43, A61K2300/00 (EP);
A61K31/445, A61K2300/00 (EP);
A61K31/44, A61K2300/00 (EP);
A61K31/485, A61K2300/00 (EP);
A61K31/495, A61K2300/00 (EP);
A61K31/505, A61K2300/00 (EP);
A61K31/54, A61K2300/00 (EP);
A61K31/54, A61K31/485, A61K31/43, A61K31/135 (EP);
A61K31/60, A61K2300/00 (EP);
A61K31/60, A61K31/505, A61K31/42, A61K31/495, A61K31/445, A61K31/44, A61K31/195, A61K31/165, A61K31/19, A61K31/135 (EP)
(-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [1993/10]
TitleGerman:VERWENDUNG VON PHENYLPROPANOLAMIN ALS IM OBEREN RESPIRATIONSTRAKT WIRKENDES DIE SCHLEIMSEKRETION FÖRDERNDES MITTEL[1993/10]
English:THE USE OF PHENYLPROPANOLAMINE AS A MUCUS SECRETAGOGUE IN THE UPPER AIRWAYS[1993/10]
French:UTILISATION DE PHENYLPROPANOLAMINE COMME SECRETAGOGUE MUQUEUX DES VOIES RESPIRATOIRES SUPERIEURES[1993/10]
File destroyed:20.04.2002
Entry into regional phase12.11.1992National basic fee paid 
12.11.1992Designation fee(s) paid 
12.11.1992Examination fee paid 
Examination procedure21.11.1991Request for preliminary examination filed
International Preliminary Examining Authority: DE
12.11.1992Examination requested  [1993/10]
30.09.1994Despatch of a communication from the examining division (Time limit: M06)
20.06.1995Reply to a communication from the examining division
12.02.1996Despatch of a communication from the examining division (Time limit: M04)
25.06.1996Application deemed to be withdrawn, date of legal effect  [1996/51]
24.07.1996Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [1996/51]
Request for further processing for:20.06.1995Request for further processing filed
20.06.1995Full payment received (date of receipt of payment)
Request granted
04.07.1995Decision despatched
Fees paidRenewal fee
12.11.1992Renewal fee patent year 03
09.05.1994Renewal fee patent year 04
12.04.1995Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.199606   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US4818541  (SANDERSON JOHN E [US])
 [X]  - The Journal of Pediatrics, vol. 101, no. 1, June 1982, The C.V. Mosby Co., D.M. Moran et al.: "The use of an antihistamine-decongestant in conjunction with an anti-infective drug in the treatment of acute otitis media", pages 132-136, see the whole article
 [X]  - MARTINDALE The Extra Pharmacopoeia, 29th edition, edited by J.E.F. Reynolds, 1989, The Pharmaceutical Press, (London, GB), pages 1475-1477, see monographe 2095-q: "Phenylpropanolamine hydrochloride"
 [X]  - American Drug Index, 26th Edition, N.F. Billups, 1982, J.B. Lippincott Co., (Philadelphia, US), page 227, see "Entex"
 [X]  - The Merck Manual of Diagnosis and Therapy, 15th edition, R. Berkow, 1987, Merck Sharp & Dohme Research Laboratories, (Rahway, N.J., US), see pages 2180,2181,2196,2197
 [A]  - Journal of Pharmaceutical Sciences, vol. 76, no. 2, February 1987, American Pharmaceutical Association, F.A. Moya-Huff et al.: "Cardiovascular differences between phenylpropanolamine and its related norephedrine isomers in the rat", pages 114-116, see the whole article
 [A]  - The FASEB Journal, vol. 2, no. 5, 20 March 1988, abstract 5388, M. Eisenberg et al.: "A comparison of anorectic and locomotor response to d,l-norephedrine, its component and related isomers", page A1223, see the abstract
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.